UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 137

Sortiert nach

Correlative analyses of RET and RAS mutations in a phase 3 trial of cabozantinib in patients with progressive, metastatic medullary thyroid cancer

Cancer, 2016-12, Vol.122 (24), p.3856-3864

2016

Volltextzugriff (PDF)

Exposure-response modeling of cabozantinib in patients with renal cell carcinoma: Implications for patient care

Cancer treatment reviews, 2020-09, Vol.89, p.102062-102062, Article 102062

2020

Volltextzugriff (PDF)

Phase I evaluation of XL019, an oral, potent, and selective JAK2 inhibitor

Leukemia research, 2014-03, Vol.38 (3), p.316-322

2014

Volltextzugriff (PDF)

Analysis by region of outcomes for patients with advanced renal cell carcinoma treated with cabozantinib or everolimus: a sub-analysis of the METEOR study

Acta oncologica, 2022-01, Vol.61 (1), p.52-57

2022

Volltextzugriff (PDF)

Pharmacological Abrogation of S-Phase Checkpoint Enhances the Anti-Tumor Activity of Gemcitabine In Vivo

Cell cycle (Georgetown, Tex.), 2007-01, Vol.6 (1), p.104-110

2007

Volltextzugriff (PDF)

Phase I study of XL281 (BMS-908662), a potent oral RAF kinase inhibitor, in patients with advanced solid tumors

Investigational new drugs, 2015-04, Vol.33 (2), p.349-356

2015

Volltextzugriff (PDF)

Anaplastic lymphoma kinase is dynamically expressed on subsets of motor neurons and in the peripheral nervous system

Journal of comparative neurology (1911), 2006-03, Vol.495 (2), p.202-212

2006

Volltextzugriff (PDF)

The carbonic anhydrase domain of receptor tyrosine phosphatase β is a functional ligand for the axonal cell recognition molecule contactin

Cell, 1995-07, Vol.82 (2), p.251-260

1995

Volltextzugriff (PDF)

Postnatal Changes in the Expression of the trkA High-affinity NGF Receptor in Primary Sensory Neurons

The European journal of neuroscience, 1996-10, Vol.8 (10), p.2204-2208

1996

Volltextzugriff (PDF)

An Alternatively Spliced Form of the Nerve Growth Factor Receptor TrkA Confers an Enhanced Response to Neurotrophin 3

Proceedings of the National Academy of Sciences - PNAS, 1994-11, Vol.91 (23), p.11133-11137

1994

Volltextzugriff (PDF)

SNAP family of NSF attachment proteins includes a brain-specific isoform

Nature (London), 1993-03, Vol.362 (6418), p.353-355

1993

Volltextzugriff (PDF)

Neurotrophin-3 Promotes the Differentiation of Muscle Spindle Afferents in the Absence of Peripheral Targets

The Journal of neuroscience, 1997-06, Vol.17 (11), p.4262-4274

1997

Volltextzugriff (PDF)

Inhibition of the NT-3 Receptor TrkC, Early in Chick Embryogenesis, Results in Severe Reductions in Multiple Neuronal Subpopulations in the Dorsal Root Ganglia

The Journal of neuroscience, 1996-06, Vol.16 (11), p.3704-3713

1996

Volltextzugriff (PDF)

A Novel 115-kD Peripheral Membrane Protein Is Required for Intercisternal Transport in the Golgi Stack

The Journal of cell biology, 1992-09, Vol.118 (5), p.1015-1026

1992

Volltextzugriff (PDF)

SNAPs, a family of NSF attachment proteins involved in intracellular membrane fusion in animals and yeast

Cell, 1990-05, Vol.61 (4), p.709-721

1990

Volltextzugriff (PDF)

Clinical outcomes by nephrectomy status in METEOR, a randomized phase 3 trial of cabozantinib (cabo) vs everolimus (eve) in patients (pts) with advanced renal cell carcinoma (RCC)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.4570-4570

2017

Volltextzugriff (PDF)

An automated image capture and quantitation approach to identify proteins affecting tumor cell proliferation

Journal of biomolecular screening, 2004-04, Vol.9 (3), p.216-222

2004

Volltextzugriff (PDF)

Effects of Cabozantinib Alone and in Combination with Bortezomib in the 5TGM1 Murine Multiple Myeloma Model

Blood, 2014-12, Vol.124 (21), p.3442-3442

2014

Volltextzugriff (PDF)

Abstract 734: Effects of Cabozantinib in the 5TGM1 murine multiple myeloma model

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.734-734

2014

Volltextzugriff (PDF)

TrkA Activation Is Sufficient to Rescue Axotomized Cholinergic Neurons

Neuron (Cambridge, Mass.), 1996-03, Vol.16 (3), p.653-663

1996

Volltextzugriff (PDF)

Transcriptional-based screens for pathway-specific, high-throughput target discovery in endothelial cells

Journal of biomolecular screening, 2004-12, Vol.9 (8), p.704-711

2004

Volltextzugriff (PDF)

Clinical Outcomes by Nephrectomy Status In METEOR, A Randomized Phase 3 Trial of Cabozantinib Versus Everolimus in Patients with Advanced Renal Cell Carcinoma

Kidney cancer, 2020-03, Vol.4 (1), p.29-39

2020

Volltextzugriff (PDF)

Efficacy of cabozantinib (Cabo) in medullary thyroid cancer (MTC) patients with RAS or RET mutations: Results from a phase III study

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.6000-6000

2013

Volltextzugriff (PDF)

Abstract 2487: A multi-kinase inhibitor, XL228, enhanced human cancer cell radiosensitivity and suppressed cell invasion and migration

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.2487-2487

2011

Volltextzugriff (PDF)

Sequence evolution of drosophila mitochondrial DNA

Genetics (Austin), 1985-04, Vol.109 (4), p.725-744

1985

Volltextzugriff (PDF)

1 – 25 von 137

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(130)
Mit Volltextzugriff
(125)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(137)
Japanisch
(29)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Correlative analyses of RET and RAS mutations in a phase 3 trial of cabozantinib in patients with progressive, metastatic medullary thyroid cancer

Exposure-response modeling of cabozantinib in patients with renal cell carcinoma: Implications for patient care

Phase I evaluation of XL019, an oral, potent, and selective JAK2 inhibitor

Analysis by region of outcomes for patients with advanced renal cell carcinoma treated with cabozantinib or everolimus: a sub-analysis of the METEOR study

Pharmacological Abrogation of S-Phase Checkpoint Enhances the Anti-Tumor Activity of Gemcitabine In Vivo

Phase I study of XL281 (BMS-908662), a potent oral RAF kinase inhibitor, in patients with advanced solid tumors

Anaplastic lymphoma kinase is dynamically expressed on subsets of motor neurons and in the peripheral nervous system

The carbonic anhydrase domain of receptor tyrosine phosphatase β is a functional ligand for the axonal cell recognition molecule contactin

Postnatal Changes in the Expression of the trkA High-affinity NGF Receptor in Primary Sensory Neurons

An Alternatively Spliced Form of the Nerve Growth Factor Receptor TrkA Confers an Enhanced Response to Neurotrophin 3

SNAP family of NSF attachment proteins includes a brain-specific isoform

Neurotrophin-3 Promotes the Differentiation of Muscle Spindle Afferents in the Absence of Peripheral Targets

Inhibition of the NT-3 Receptor TrkC, Early in Chick Embryogenesis, Results in Severe Reductions in Multiple Neuronal Subpopulations in the Dorsal Root Ganglia

A Novel 115-kD Peripheral Membrane Protein Is Required for Intercisternal Transport in the Golgi Stack

SNAPs, a family of NSF attachment proteins involved in intracellular membrane fusion in animals and yeast

Clinical outcomes by nephrectomy status in METEOR, a randomized phase 3 trial of cabozantinib (cabo) vs everolimus (eve) in patients (pts) with advanced renal cell carcinoma (RCC)

An automated image capture and quantitation approach to identify proteins affecting tumor cell proliferation

Effects of Cabozantinib Alone and in Combination with Bortezomib in the 5TGM1 Murine Multiple Myeloma Model

Abstract 734: Effects of Cabozantinib in the 5TGM1 murine multiple myeloma model

TrkA Activation Is Sufficient to Rescue Axotomized Cholinergic Neurons

Transcriptional-based screens for pathway-specific, high-throughput target discovery in endothelial cells

Clinical Outcomes by Nephrectomy Status In METEOR, A Randomized Phase 3 Trial of Cabozantinib Versus Everolimus in Patients with Advanced Renal Cell Carcinoma

Efficacy of cabozantinib (Cabo) in medullary thyroid cancer (MTC) patients with RAS or RET mutations: Results from a phase III study

Abstract 2487: A multi-kinase inhibitor, XL228, enhanced human cancer cell radiosensitivity and suppressed cell invasion and migration

Sequence evolution of drosophila mitochondrial DNA

Suchergebnisse filtern